Wolverine Trading’s Vir Biotechnology VIR Stock Holding History

Wolverine Trading’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-11,400	Closed	-$101K	–	5421
2024 Q2	$101K	Buy	+11,400	New	+$109K	﹤0.01%	4062
2023 Q1	–	Sell	-9,200	Closed	-$233K	–	5019
2022 Q4	$233K	Buy	+9,200	New	+$225K	﹤0.01%	2992
2022 Q3	–	Sell	-15,000	Closed	-$390K	–	5424
2022 Q2	$390K	Buy	+15,000	New	+$350K	﹤0.01%	2785
2022 Q1	–	Sell	-29,700	Closed	-$1.21M	–	6530
2021 Q4	$1.21M	Buy	29,700 +14,500	+95%	+$568K	﹤0.01%	2410
2021 Q3	$656K	Buy	15,200 +7,100	+88%	+$307K	﹤0.01%	3563
2021 Q2	$377K	Sell	8,100 -10,800	-57%	-$491K	﹤0.01%	4098
2021 Q1	$903K	Buy	+18,900	New	+$1.02M	﹤0.01%	2891

Other funds holding VIR

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wolverine Trading's VIR Position: Q3 2025 in Review

Wolverine Trading opened a new position in Vir Biotechnology (VIR) in Q3 2025: 12,141 shares worth $68.4K. The stake represents ﹤0.01% of the portfolio and ranks #5337 among its holdings. This is a return to the name: Wolverine Trading previously reported a position in VIR as recently as Q4 2024.

Wolverine Trading first reported a position in VIR in Q2 2021 and has held it in 5 quarters since. The position peaked at $660K in Q4 2021. 213 funds tracked by Wall St. Rank hold VIR as of Q3 2025.

Wolverine Trading held 12,141 shares of Vir Biotechnology worth $68.4K as of Q3 2025.
Vir Biotechnology was a new Wolverine Trading position in Q3 2025.
Vir Biotechnology made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #5337 holding.
Wolverine Trading first reported a position in Vir Biotechnology in Q2 2021 and has held it in 5 quarters since.
Wolverine Trading's Vir Biotechnology position peaked at $660K in Q4 2021.
213 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.